Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
Conditions:   Soft Tissue Sarcoma Adult;   Undifferentiated Pleomorphic Sarcoma;   Epithelioid Sarcoma;   Solitary Fibrous Tumors;   Hemangioendothelioma;   Desmoplastic Round Cell Tumor;   Synovial Sarcoma Intervention:   Drug: Trabectedin Sponsor:   Institut Bergonié Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2019 Category: Research Source Type: clinical trials